3NCL image
Deposition Date 2010-06-04
Release Date 2011-02-16
Last Version Date 2024-10-16
Entry Detail
PDB ID:
3NCL
Keywords:
Title:
Crystal Structure of MT-SP1 bound to Benzamidine Phosphonate Inhibitor
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.19 Å
R-Value Free:
0.15
R-Value Work:
0.13
R-Value Observed:
0.13
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Suppressor of tumorigenicity 14 protein
Gene (Uniprot):ST14
Mutagens:C731S
Chain IDs:A
Chain Length:241
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Peptide length and leaving-group sterics influence potency of Peptide phosphonate protease inhibitors.
Chem.Biol. 18 48 57 (2011)
PMID: 21276938 DOI: 10.1016/j.chembiol.2010.11.007

Abstact

The ability to follow enzyme activity in a cellular context represents a challenging technological frontier that impacts fields ranging from disease pathogenesis to epigenetics. Activity-based probes (ABPs) label the active form of an enzyme via covalent modification of catalytic residues. Here we present an analysis of parameters influencing potency of peptide phosphonate ABPs for trypsin-fold S1A proteases, an abundant and important class of enzymes with similar substrate specificities. We find that peptide length and stability influence potency more than sequence composition and present structural evidence that steric interactions at the prime-side of the substrate-binding cleft affect potency in a protease-dependent manner. We introduce guidelines for the design of peptide phosphonate ABPs and demonstrate their utility in a live-cell labeling application that specifically targets active S1A proteases at the cell surface of cancer cells.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback